Researchers have used AI to find adalimumab effective for iMCD, highlighting the potential of machine learning in discovering ...
SALT LAKE CITY, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic tumor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback